Table of Contents
International Scholarly Research Notices
Volume 2016 (2016), Article ID 9351787, 9 pages
http://dx.doi.org/10.1155/2016/9351787
Research Article

Studies on Shokyo, Kanzo, and Keihi in Kakkonto Medicine on Prostaglandin E2 Production in Lipopolysaccharide-Treated Human Gingival Fibroblasts

Department of Pharmacology, Matsumoto Dental University, 1780 Gobara Hirooka, Shiojiri, Nagano 399-0781, Japan

Received 31 May 2016; Revised 22 July 2016; Accepted 26 September 2016

Academic Editor: Fong-Fu Hsu

Copyright © 2016 Toshiaki Ara and Norio Sogawa. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Noguchi and I. Ishikawa, “The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease,” Periodontology 2000, vol. 43, no. 1, pp. 85–101, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Ozaki, “Studies on antiinflammatory effect of Japanese oriental medicines (kampo medicines) used to treat inflammatory diseases,” Biological and Pharmaceutical Bulletin, vol. 18, no. 4, pp. 559–562, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Yamamoto, K. Fujiwara, M. Yoshida et al., “Therapeutic effect of kakkonto in a mouse model of food allergy with gastrointestinal symptoms,” International Archives of Allergy and Immunology, vol. 148, no. 3, pp. 175–185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Nagasaka, M. Kurokawa, M. Imakita, K. Terasawa, and K. Shiraki, “Efficacy of Kakkon-to, a traditional herb medicine, in herpes simplex virus type 1 infection in mice,” Journal of Medical Virology, vol. 46, no. 1, pp. 28–34, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Kurokawa, M. Tsurita, J. Brown, Y. Fukuda, and K. Shiraki, “Effect of interleukin-12 level augmented by Kakkon-to, a herbal medicine, on the early stage of influenza infection in mice,” Antiviral Research, vol. 56, no. 2, pp. 183–188, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. M.-S. Wu, H.-R. Yen, C.-W. Chang et al., “Mechanism of action of the suppression of influenza virus replication by Ko-Ken Tang through inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway and viral RNP nuclear export,” Journal of Ethnopharmacology, vol. 134, no. 3, pp. 614–623, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J. S. Chang, K. C. Wang, D. E. Shieh, F. F. Hsu, and L. C. Chiang, “Ge-Gen-Tang has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines,” Journal of Ethnopharmacology, vol. 139, no. 1, pp. 305–310, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Kutsuwa, N. Nakahata, M. Kubo, K. Hayashi, and Y. Ohizumi, “A comparative study of Kakkon-to and Keishi-to on prostaglandin E2 release from rabbit astrocytes,” Phytomedicine, vol. 5, no. 4, pp. 275–282, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Kitamura, H. Urano, and T. Ara, “Preventive effects of a kampo medicine, kakkonto, on inflammatory responses via the suppression of extracellular signal-regulated kinase phosphorylation in lipopolysaccharide-treated human gingival fibroblasts,” ISRN Pharmacology, vol. 2014, Article ID 784019, 7 pages, 2014. View at Publisher · View at Google Scholar
  10. N. Horie, K. Hashimoto, T. Kato et al., “COX-2 as possible target for the inhibition of PGE2 production by Rikko-san activated macrophage,” In Vivo, vol. 22, no. 3, pp. 333–336, 2008. View at Google Scholar · View at Scopus
  11. Y. Nakazono, T. Ara, Y. Fujinami, T. Hattori, and P.-L. Wang, “Preventive effects of a kampo medicine, hangeshashinto on inflammatory responses in lipopolysaccharide-treated human gingival fibroblasts,” Journal of Hard Tissue Biology, vol. 19, no. 1, pp. 43–50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Ara, K.-I. Honjo, Y. Fujinami, T. Hattori, Y. Imamura, and P.-L. Wang, “Preventive effects of a kampo medicine, orento on inflammatory responses in lipopolysaccharide treated human gingival fibroblasts,” Biological and Pharmaceutical Bulletin, vol. 33, no. 4, pp. 611–616, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. E. Burke and E. A. Dennis, “Phospholipase A2 biochemistry,” Cardiovascular Drugs and Therapy, vol. 23, no. 1, pp. 49–59, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Afzal, D. Al-Hadidi, M. Menon, J. Pesek, and M. S. I. Dhami, “Ginger: an ethnomedical, chemical and pharmacological review,” Drug Metabolism and Drug Interactions, vol. 18, no. 3-4, pp. 159–190, 2001. View at Google Scholar · View at Scopus
  15. T.-J. Lin, C.-F. Yeh, K.-C. Wang, L.-C. Chiang, J.-J. Tsai, and J.-S. Chang, “Water extract of Pueraria lobata Ohwi has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines,” Kaohsiung Journal of Medical Sciences, vol. 29, no. 12, pp. 651–657, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Wilborn, L. J. Crofford, M. O. Burdick, S. L. Kunkel, R. M. Strieter, and M. Peters- Golden, “Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2,” The Journal of Clinical Investigation, vol. 95, no. 4, pp. 1861–1868, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Takayama, I. Kudo, D. K. Kim, K. Nagata, Y. Nozawa, and K. Inoue, “Purification and characterization of human platelet phospholipase A2 which preferentially hydrolyzes an arachidonoyl residue,” FEBS Letters, vol. 282, no. 2, pp. 326–330, 1991. View at Publisher · View at Google Scholar · View at Scopus
  18. D. J. Macdonald, R. M. Boyle, A. C. A. Glen, and D. F. Horrobin, “Cytosolic phospholipase A2 type IVA is present in human red cells,” Blood, vol. 103, no. 9, pp. 3562–3564, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Gupta, M. Katsumata, A. S. Goldman, R. Herold, and R. Piddington, “Glucocorticoid-induced phospholipase A2-inhibitory proteins mediate glucocorticoid teratogenicity in vitro,” Proceedings of the National Academy of Sciences of the United States of America, vol. 81, no. 4, pp. 1140–1143, 1984. View at Publisher · View at Google Scholar · View at Scopus
  20. B. P. Wallner, R. J. Mattaliano, C. Hession et al., “Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity,” Nature, vol. 320, no. 6057, pp. 77–81, 1986. View at Publisher · View at Google Scholar · View at Scopus
  21. L.-L. Lin, M. Wartmann, A. Y. Lin, J. L. Knopf, A. Seth, and R. J. Davis, “cPLA2 is phosphorylated and activated by MAP kinase,” Cell, vol. 72, no. 2, pp. 269–278, 1993. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. Gijón, D. M. Spencer, A. L. Kaiser, and C. C. Leslie, “Role of phosphorylation sites and the C2 domain in regulation of cytosolic phospholipase A2,” The Journal of Cell Biology, vol. 145, no. 6, pp. 1219–1232, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. S. E. Lakhan, C. T. Ford, and D. Tepper, “Zingiberaceae extracts for pain: a systematic review and meta-analysis,” Nutrition Journal, vol. 14, no. 1, article 50, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Thomson, K. K. Al-Qattan, S. M. Al-Sawan, M. A. Alnaqeeb, I. Khan, and M. Ali, “The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 67, no. 6, pp. 475–478, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Aimbire, S. C. Penna, M. Rodrigues, K. C. Rodrigues, R. A. B. Lopes-Martins, and J. A. A. Sertié, “Effect of hydroalcoholic extract of Zingiber officinalis rhizomes on LPS-induced rat airway hyperreactivity and lung inflammation,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 77, no. 3-4, pp. 129–138, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. H. S. El-Abhar, L. N. A. Hammad, and H. S. A. Gawad, “Modulating effect of ginger extract on rats with ulcerative colitis,” Journal of Ethnopharmacology, vol. 118, no. 3, pp. 367–372, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. R. B. van Breemen, Y. Tao, and W. Li, “Cyclooxygenase-2 inhibitors in ginger (Zingiber officinale),” Fitoterapia, vol. 82, no. 1, pp. 38–43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Tjendraputra, V. H. Tran, D. Liu-Brennan, B. D. Roufogalis, and C. C. Duke, “Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells,” Bioorganic Chemistry, vol. 29, no. 3, pp. 156–163, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. R. C. Lantz, G. J. Chen, M. Sarihan, A. M. Sólyom, S. D. Jolad, and B. N. Timmermann, “The effect of extracts from ginger rhizome on inflammatory mediator production,” Phytomedicine, vol. 14, no. 2-3, pp. 123–128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Nievergelt, J. Marazzi, R. Schoop, K.-H. Altmann, and J. Gertsch, “Ginger phenylpropanoids inhibit IL-1β and prostanoid secretion and disrupt arachidonate-phospholipid remodeling by targeting phospholipases A2,” Journal of Immunology, vol. 187, no. 8, pp. 4140–4150, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Ohto, N. Uozumi, T. Hirabayashi, and T. Shimizu, “Identification of novel cytosolic phospholipase A2s, murine cPLA2δ, ε, and ζ, which form a gene cluster with cPLA2β,” The Journal of Biological Chemistry, vol. 280, no. 26, pp. 24576–24583, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. C. C. Leslie, “Properties and regulation of cytosolic phospholipase A2,” The Journal of Biological Chemistry, vol. 272, no. 27, pp. 16709–16712, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Shibata, “A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice,” Yakugaku Zasshi, vol. 120, no. 10, pp. 849–862, 2000. View at Google Scholar · View at Scopus
  34. T. Kaneko, H. Chiba, N. Horie et al., “Effect of Sairei-to and its ingredients on prostaglandin E2 production by mouse macrophage-like cells,” In Vivo, vol. 22, no. 5, pp. 571–575, 2008. View at Google Scholar · View at Scopus
  35. Y. Kase, K. Saitoh, A. Ishige, and Y. Komatsu, “Mechanisms by which Hange-shashin-to reduces prostaglandin E2 levels,” Biological and Pharmaceutical Bulletin, vol. 21, no. 12, pp. 1277–1281, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Takahashi, N. Takasuka, M. Iigo et al., “Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development,” Cancer Science, vol. 95, no. 5, pp. 448–453, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. J.-Y. Kim, S. J. Park, K.-J. Yun, Y.-W. Cho, H.-J. Park, and K.-T. Lee, “Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-κB in RAW 264.7 macrophages,” European Journal of Pharmacology, vol. 584, no. 1, pp. 175–184, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. J.-H. Song, J.-W. Lee, B. Shim et al., “Glycyrrhizin alleviates neuroinflammation and memory deficit induced by systemic lipopolysaccharide treatment in mice,” Molecules, vol. 18, no. 12, pp. 15788–15803, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. J.-Y. Yu, J. Y. Ha, K.-M. Kim, Y.-S. Jung, J.-C. Jung, and S. Oh, “Anti-inflammatory activities of licorice extract and its active compounds, glycyrrhizic acid, liquiritin and liquiritigenin, in BV2 cells and mice liver,” Molecules, vol. 20, no. 7, pp. 13041–13054, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. J.-C. Liao, J.-S. Deng, C.-S. Chiu et al., “Anti-inflammatory activities of Cinnamomum cassia constituents in vitro and in vivo,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 429320, 12 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Yu, S. Lee, W. S. Yang et al., “The ability of an ethanol extract of Cinnamomum cassia to inhibit Src and spleen tyrosine kinase activity contributes to its anti-inflammatory action,” Journal of Ethnopharmacology, vol. 139, no. 2, pp. 566–573, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. L. T. Vaszar and D. D. Stevenson, “Aspirin-induced asthma,” Clinical Reviews in Allergy and Immunology, vol. 21, no. 1, pp. 71–87, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Bochenek, K. Bánska, Z. Szabó, E. Nizankowska, and A. Szczeklik, “Diagnosis, prevention and treatment of aspirin-induced asthma and rhinitis,” Current Drug Target—Inflammation & Allergy, vol. 1, no. 1, pp. 1–11, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. Z. Wang, J. Hasegawa, X. Wang et al., “Protective effects of ginger against aspirin-induced gastric ulcers in rats,” Yonago Acta Medica, vol. 54, no. 1, pp. 11–19, 2011. View at Google Scholar · View at Scopus